Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederik Giesel

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
International Journal of Molecular Sciences|November 9, 2024
Evaluation of Targeted Alpha Therapy Using [<sup>211</sup>At]FAPI1 in Triple-Negative Breast Cancer Xenograft ModelsKaori Abe, Tadashi Watabe, Kazuko Kaneda-Nakashima, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2017
<sup>68</sup>Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2017
Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesionsStefano Fanti, Silvia Minozzi, Joshua James Morigi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 19, 2016
Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in <sup>68</sup>Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRIMartin T Freitag, Jan P Radtke, Ali Afshar-Oromieh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 11, 2024
Diagnostic Potential of Supplemental Static and Dynamic <sup>68</sup>Ga-FAPI-46 PET for Primary <sup>18</sup>F-FDG-Negative Pulmonary LesionsManuel Röhrich, Johanna Daum, Ewgenija Gutjahr, et al.
British Journal of Cancer|March 17, 2022
Fibroblast activation protein identifies Consensus Molecular Subtype 4 in colorectal cancer and allows its detection by <sup>68</sup>Ga-FAPI-PET imagingEsther Strating, Emma Wassenaar, Mathijs Verhagen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2024
Impact of <sup>18</sup>F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center TrialKai Jannusch, Lale Umutlu, Julian Kirchner, et al.
International Journal of Cancer|September 19, 2022
Adherence to a risk-adapted screening strategy for prostate cancer: First results of the PROBASE trialAgne Krilaviciute, Peter Albers, Jale Lakes, et al.
European Urology|June 3, 2025
Prostate Cancer Detection in Younger Men: A Comparative Analysis of Systematic and Magnetic Resonance Imaging-targeted Biopsy in the PROBASE TrialRouvier Al-Monajjed, Matthias Boschheidgen, Jale Lakes, et al.
European Urology Oncology|November 11, 2025
Value of Additional Systematic Cores During Magnetic Resonance Imaging-guided Targeted Biopsy in Prostate Cancer Screening for Young Men: Results from the PROBASE TrialRouvier Al-Monajjed, Matthias Boschheidgen, Jale Lakes, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Sciences|November 9, 2024
Evaluation of Targeted Alpha Therapy Using [<sup>211</sup>At]FAPI1 in Triple-Negative Breast Cancer Xenograft ModelsKaori Abe, Tadashi Watabe, Kazuko Kaneda-Nakashima, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2017
<sup>68</sup>Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2017
Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesionsStefano Fanti, Silvia Minozzi, Joshua James Morigi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 19, 2016
Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in <sup>68</sup>Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRIMartin T Freitag, Jan P Radtke, Ali Afshar-Oromieh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 11, 2024
Diagnostic Potential of Supplemental Static and Dynamic <sup>68</sup>Ga-FAPI-46 PET for Primary <sup>18</sup>F-FDG-Negative Pulmonary LesionsManuel Röhrich, Johanna Daum, Ewgenija Gutjahr, et al.
British Journal of Cancer|March 17, 2022
Fibroblast activation protein identifies Consensus Molecular Subtype 4 in colorectal cancer and allows its detection by <sup>68</sup>Ga-FAPI-PET imagingEsther Strating, Emma Wassenaar, Mathijs Verhagen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2024
Impact of <sup>18</sup>F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center TrialKai Jannusch, Lale Umutlu, Julian Kirchner, et al.
International Journal of Cancer|September 19, 2022
Adherence to a risk-adapted screening strategy for prostate cancer: First results of the PROBASE trialAgne Krilaviciute, Peter Albers, Jale Lakes, et al.
European Urology|June 3, 2025
Prostate Cancer Detection in Younger Men: A Comparative Analysis of Systematic and Magnetic Resonance Imaging-targeted Biopsy in the PROBASE TrialRouvier Al-Monajjed, Matthias Boschheidgen, Jale Lakes, et al.
European Urology Oncology|November 11, 2025
Value of Additional Systematic Cores During Magnetic Resonance Imaging-guided Targeted Biopsy in Prostate Cancer Screening for Young Men: Results from the PROBASE TrialRouvier Al-Monajjed, Matthias Boschheidgen, Jale Lakes, et al.
Pageof 7